कृपया अन्य खोज का प्रयास करें
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Karen K. McGinnis | 56 | 2020 | Lead Independent Director |
Daniel A. Rabinovitsj | 58 | 2022 | Independent Director |
Amrit Nagpal | 48 | 2020 | Independent Director |
Joseph Sirosh | 54 | 2022 | Independent Director |
Timothy K. Lu | 42 | 2023 | Member of Scientific Advisory Board |
Victor Greiff | - | 2023 | Member of Scientific Advisory Board |
Hubert Truebel | - | 2023 | Member of Scientific Advisory Board |
Sean McClain | 34 | 2011 | Founder, CEO, President & Director |
Andreas Busch | 61 | 2022 | Chief Innovation Officer & Member of Scientific Advisory Board |
François Adrianus van Houten | 64 | 2023 | Independent Director |
Menelas Nicolas Pangalos | 57 | 2024 | Independent Director & Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है